Peptilogics
  • Company
    • Purpose
    • Team
    • Investors & Partners
  • AI Platform
    • Power of Peptides
    • Human+AI Peptide Engineering
  • Pipeline
    • Lead Program: PLG0206
    • HCP Resources
  • Patients
    • Supporting Patients with PJI
    • PJI Support Group
    • Living with PJI
    • About PJI
    • Clinical Trials
    • Expanded Access Policy
  • Careers
    • Mission & Values
    • Life at Peptilogics
    • Current Openings
  • News
    • Press Releases
    • Publications
    • Presentations
  • Contact
    • Twitter
    • Facebook
    • LinkedIn
    • YouTube
  • Search
  • Menu Menu

David Huang, MD, PhD

SVP & Chief Medical Officer

Dr. David Huang serves as the Chief Medical Officer of Peptilogics and has approximately 20 years of clinical, academic, industry and research experience in infectious diseases and is well-versed in the design, execution of Phase I – III clinical trials for both antibacterials and antiviral agents. He also serves as an attending physician at the Department of Veterans Affairs and has had increasing responsibilities and leadership positions at Pfizer, ContraFect Corp and Motif Bio. Dr. Huang earned his MD and PhD in Epidemiology from the University of Texas at School of Medicine and School of Public Health.

  • Company
    • Purpose
    • Team
    • Investors & Partners
  • AI Platform
    • Power of Peptides
    • Human+AI Peptide Engineering
  • Pipeline
    • Lead Program: PLG0206
    • HCP Resources
  • Patients
    • Supporting Patients with PJI
    • PJI Support Group
    • Living with PJI
    • About PJI
    • Clinical Trials
    • Expanded Access Policy
  • Careers
    • Mission & Values
    • Life at Peptilogics
    • Current Openings
  • News
    • Press Releases
    • Publications
    • Presentations
  • Contact
    • Twitter
    • Facebook
    • LinkedIn
    • YouTube
© 2023 Peptilogics, All Rights Reserved | Privacy Policy | Terms of Use
Scroll to top